Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | Director | August 11, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date August 11, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 308,413 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Grant · Acquired 35,000 · Balance 308,413 F1: The grant of restricted shares vests on June 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The grant of restricted shares vests on June 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 14, 2026 01:24 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-26-001097 · form4.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,413 F1 · shares: The grant of restricted shares vests on June 1, 2027. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 22:53 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 22,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001041 · form4.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,413 F1 · shares: The grant of restricted shares vests on June 1, 2026. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:28 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-24-000865 · form4.xml · nonDerivative · entry 2 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,048 F2 · shares: The grant of restricted shares vests immediately Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:28 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 24,648 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-24-000865 · form4.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,048 F1 · shares: The grant of restricted shares vests on June 1, 2025 F3 · balance_after: The beneficial holdings have been updated to accurately reflect an exercise of 75,000 shares from an option exercise on June 14, 2024 and previously unaccounted for holdings. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 15:18 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 2,000 | $3.28 | $6,560.00 |
DisclosureSEC source: 0001362118-22-000021 · primary_doc.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 19:57 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 2,000 | $4.89 | $9,780.00 |
DisclosureSEC source: 0001362118-21-000044 · primary_doc.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 17:48 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-023470 · ownership.xml · derivative · entry 2 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock, par value $0.01 · 8,000 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on September 30, 2021 and additional RSUs will vest quarterly thereafter providing that the Reporting Person remains in continuous service on each vesting date. The final quarterly vesting will occur on the earlier of the date of the next annual stockholders' meeting or June 30, 2022. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 19:24 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 2,000 | $6.78 | $13,566.40 |
DisclosureSEC source: 0001362118-21-000031 · primary_doc.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:07 UTC | LifeMD, Inc. LFMD · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 2,000 | $10.44 | $20,880.00 |
DisclosureSEC source: 0001362118-21-000016 · primary_doc.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Read SEC document |
| October 16, 2018 Filed Oct 25, 2018 13:25 UTC | LifeMD, Inc. CVLB · Entity 6521 | OtherOption · Derivative | 352,500 | $0.20 Strike: $0.20 | $70,500.00 |
DisclosureSEC source: 0001213900-18-014444 · ownership.xml · derivative · entry 7 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,500 Underlying: Common Stock , par value $0.01 · 352,500 shares Expires 2023-10-12 F1 · kind: The 352,500 options were assigned to the Reporting Person by a third party as consideration for consulting services. Read SEC document |
| September 12, 2018 Filed Oct 25, 2018 13:25 UTC | LifeMD, Inc. CVLB · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 5,000 | $0.26 | $1,303.00 |
DisclosureSEC source: 0001213900-18-014444 · ownership.xml · nonDerivative · entry 2 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Read SEC document |
| September 12, 2018 Filed Oct 25, 2018 13:25 UTC | LifeMD, Inc. CVLB · Entity 6521 | PurchaseCommon Stock, par value $0.01 | 5,000 | $0.27 | $1,350.00 |
DisclosureSEC source: 0001213900-18-014444 · ownership.xml · nonDerivative · entry 1 DiTrolio Joseph · CIK 0001721836 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.